Dr. Burzeen Eruch Karanjawala, MD

Dr. Karanjawala practices at Sacramento Colon & Rectal Surgery Medical Group, Inc. in Sacramento, California.

Dr. Karanjawala's NPI, 1730438037, was assigned on August 31, 2012. Dr. Karanjawala graduated from New York Medical College in 2008. Dr. Karanjawala's California license number on file is A142182.

Dr. Karanjawala's primary practice is Sacramento Colon & Rectal Surgery Medical Group, Inc., at 1020 29th St, Sacramento, CA 95816 in Sacramento County. The practice phone is (916) 231-1050.

Dr. Karanjawala's primary practice is Sacramento Colon & Rectal Surgery Medical Group, Inc. in Sacramento, California. Dr. Karanjawala is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is Sacramento Colon and Rectal Surgery. Dmand AI also links Dr. Karanjawala to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karanjawala practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Karanjawala's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Karanjawala is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Karanjawala's licenses on file in 2 states: California and Texas.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Karanjawala treats.

CMS data shows 456 Medicare services from Dr. Karanjawala across 10 procedure codes in 2024, for 258 Medicare patients. Medicare paid $54,983 for them.

CMS counts 258 Medicare patients who saw Dr. Karanjawala in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Karanjawala's median patient age at 60, with 46% women.

In 2024, Dr. Karanjawala wrote 390 Medicare Part D claims for 254 patients. 79% of them were for generic drugs. CMS names the drug for 311 of them, across 6 drugs with 11 or more claims each, at $12,423 in total drug cost. In 2023, CMS named 259 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 72 out of 100 for Dr. Karanjawala for performance year 2024, reported as part of a group. Dr. Karanjawala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 116 procedures of colonoscopy by Dr. Karanjawala, more than 83% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Karanjawala in 2015. 2015 was the busiest year, with 2. The most frequent topics are Safety-net Providers, Tomography, X-Ray Computed and Colonic Neoplasms. Dr. Karanjawala has published most often in Dis Colon Rectum. Dr. Karanjawala's most frequent co-authors are Lillian S. Kao, MD, Stefanos G. Millas, MD and Julie Lynn Holihan, MD.

CMS Open Payments shows 60 general payments to Dr. Karanjawala from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Intuitive Surgical, Inc. paid the most, $3,487.

Dr. Karanjawala graduated from New York Medical College in 2008.

Dr. Karanjawala is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.